Stereotaxis announced that it has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...

Stereotaxis has announced the publication of initial clinical results for its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology, marking the first peer-reviewed support for its ...

ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it intends to ...

ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have ...

ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received ...

Stereotaxis’ MAGiC catheter is a robotically-navigated magnetic ablation catheter designed to perform cardiac ablation procedures that treat heart arrhythmia. The MAGiC catheter was developed based on ...